Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 800 shares, an increase of 700.0% from the June 15th total of 100 shares. Approximately 0.1% of the company’s shares are short sold. Based on […]
Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Free Report) saw a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 100 shares, a drop of 90.9% from the May 31st total of 1,100 shares. Approximately 0.0% of the company’s stock are short sold. Based on an […]
Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Free Report) was the target of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 100 shares, a decrease of 90.9% from the May 31st total of 1,100 shares. Currently, 0.0% of the shares of the company are […]
K2 Principal Fund L.P. acquired a new position in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 12,124 shares of the company’s stock, valued at approximately $124,000. K2 Principal Fund L.P. owned 0.05% of Phoenix […]
Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 6,100 shares, a drop of 16.4% from the February 28th total of 7,300 shares. Currently, 0.0% of the company’s stock are sold short. […]